|
 |
FDA Approval Activities for this Drug…
Colazal (balsalazide disodium) Capsules, Salix NDA 20-610/S1 6/18/02 6/24/02 Colazal (balsalazide disodium) Capsules, Salix NDA 20-610 7/18/00 7/25/00 7/25/00 7/31/02 Colazal Indications: Treatment of mildly to moderately active Ulcerative Colitis.
For the most up-to-date approval information, please locate this API using the drug index. |
|
|